Insulet (PODD) Cash from Operations Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -12.60% |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | -55.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.01% |
| Mar 31, 2026 | 78.37% |
| Dec 31, 2025 | 24.27% |
| Sep 30, 2025 | 16.07% |
| Jun 30, 2025 | 126.38% |
| Mar 31, 2025 | -27.17% |
| Dec 31, 2024 | 226.33% |
| Sep 30, 2024 | 93.39% |
| Jun 30, 2024 | 97.27% |
| Mar 31, 2024 | 17,420.00% |
| Dec 31, 2023 | -10.85% |
| Sep 30, 2023 | -1.23% |
| Jun 30, 2023 | 73.91% |
| Mar 31, 2023 | 103.65% |
| Dec 31, 2022 | 298.82% |
| Sep 30, 2022 | 319.77% |
| Jun 30, 2022 | 38.25% |
| Mar 31, 2022 | 60.97% |
| Dec 31, 2021 | -250.00% |
| Sep 30, 2021 | -158.37% |